The Sustainable Pathway
Following a significant name change from Cepsa to Moeve, Alfredo Lopez, Sustainability Director at Moeve Chemicals, has taken on a central role in shaping the company’s chemical business unit's sustainability outlook.
Interview
Bridging the Sim2Real Gap in Materials
Dunia Innovations Merges AI and Robotics to Accelerate Real-World Materials Discovery
Leading Transformation
As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.
Anchored in Sustainability
Dow is re-examining what it means to be resilient and competitive in a rapidly changing global landscape
Driving Sustainability Through Collaboration
Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate the development of sustainable and resilient chemical supply chains.
Driving Change Across the Industry
Christene Smith from CHEManager speaks with Christine Bunte, Managing Director of Plastics Europe Deutschland, and Miriam Olivi, President of Women in Plastics Italy.
Strategic Perspectives on Life Sciences Industry Transformation
Asahi Kasei Life Science emerges as a new growth driver, uniting bioprocess solutions, CRO, and CDMO services to shape the future of healthcare under President Ken Shinomiya’s leadership.
Bringing Biocatalytic Processes from Early Idea to Industrial Scale
Aminoverse enables players in the chemical industry to onboard more cost-efficient and sustainable manufacturing by delivering the right enzyme and process.
Beacons of the Start-up Scene, part 5: MIR Insight
Tapping into Future-oriented Synergies of Data Analysis in the Materials Sector
The Discussions are Constructive
Consultations on PFAS restriction in the EU are making progress.
Smart Tools for a Plastic-Free Future
Cutting Time and Cost of Developing Sustainable Products with AI-Powered Solutions
Motivation, Innovation, and the Power of Collaboration
Leading the Way in Pharmaceutical Manufacturing by Fostering an Agile Mindset and an Inclusive Culture.
“Access to Talent is a Crucial Factor”
In an interview with CHEManager, Edgardo Hernandez, President of Lilly Manufacturing, explains the strategy behind the ambitious investment project.
Specialty Chemicals in a Shifting World
Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.
Fostering Innovation and Collaboration
Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.
Supply Chain and Logistics Trends in the Chemical Industry
This interview covers key results of the study ‘Success Factor Supply Chain Management and Logistics in the Chemical Industry 2024’ by Solventure, Aimms and Miebach.
Data-Driven Enzyme Immobilization
Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.
High-Performance Adsorbents: The Future of Clean Industry
Porelio's FOMS adsorbents target PFAS, metals, and genotoxins, outperforming commercial solutions with unmatched selectivity, innovation, and sustainability.
Innovation at the Intersection of AI
John Banovetz, Chief Technology Officer at 3M, on the role of digital transformation in realizing the company's goals.
Next Level Chemical Distribution
Dorothee Arns, Director General of FECC, discusses current challenges, market trends and her vision for the chemical distribution industry in Europe.
Innovative and Sustainable in a Network
Röhm Strives for Global Technology Leadership as a Methacrylate Specialist.
Expert Statement: Frank Ferrante, Cambrex
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Insights into Biologics and Pharmaceutical Manufacturing
Bill Humphries, CEO of Alcami, shares his vision for the future, discussing dynamic market trends and the company’s commitment to innovation. Under his leadership, Alcami is poised to redefine the pharmaceutical and biotechnology landscape, focusing on cutting-edge solutions and navigating global complexities. This conversation highlights Alcami’s strategic direction, accomplishments, and upcoming challenges.
Uncovering Potential
Interview with Olivier Lambrechts, executive leadership team member and president NCE at Arxada.
Pharma’s Digital Transformation
Industry experts Michelangelo Canzoneri, Josef Trapl, Wolfgang Winter, Christian Woelbeling, and Thomas Zimmer – all members of ISPE’s Pharma 4.0 guide core team – explain the transformational challenges and critical success factors of the digital Pharma 4.0 journey.
Preparing for the future — TCO-optimized investments
Interview with Fernando Cruzado, Vice President and Industry Lead Chemistry, and Holger Peterkord, Senior Principal and Capex Practice Lead, Efeso Group
Expert Statement: Martin Meeson, Axplora
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Christoph Schaffrath, Lanxess
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Torsten Wöhr, Bachem
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Neil Jones, Aenova
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Victor Swint, Formulated Solutions
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Akhil Ravi, Aurigene Pharmaceutical Services
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Yu Lu, WuXi STA
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Jordi Robinson, Navin Molecular
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Greg Behar, Recipharm
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
